Vanderbilt-Ingram becomes member of prestigious cancer alliance

Vanderbilt-Ingram Cancer Center has been named a member of the National Comprehensive Cancer Network (NCCN), an alliance of the world's leading cancer centers.

The NCCN includes centers dedicated to improving the quality, effectiveness and efficiency of oncology practice so patients can live better lives. Vanderbilt-Ingram is now the organization's 21st member.

"We welcome Vanderbilt-Ingram Cancer Center to the NCCN. Vanderbilt-Ingram is one of the nation's leading cancer centers, with more than $150 million in annual research funding," said William T. McGivney, Ph.D., Chief Executive Officer of NCCN. "Through their interdisciplinary collaborative methods, VICC is highly regarded as a leader in the development and delivery of high-quality cancer care."

"Vanderbilt-Ingram is very pleased to join the NCCN," said Jennifer Pietenpol, Ph.D., interim director of Vanderbilt-Ingram. "Promising discoveries in cancer research are being made every day, but our work is not finished until those findings are translated into advances in patient care. We are excited to join this group of cancer centers to help make that happen."

Harold L. Moses, M.D., Vanderbilt-Ingram's founding director and director emeritus, noted that joining NCCN had been a longtime goal of the cancer center. "I am very pleased that we have achieved this goal and we look forward to collaborating with our colleagues to improve cancer care for patients across the country."

Vanderbilt-Ingram cares for nearly 4,000 new cancer patients each year. A National Cancer Institute-designated Comprehensive Cancer Center, Vanderbilt-Ingram is consistently ranked among the best places for cancer care by U.S. News & World Report and is among the top 10 nationally in competitively awarded NCI grant support.

The NCCN, a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.

The NCCN member institutions are:

City of Hope Cancer Center, Los Angeles, CA; Dana- Farber/Brigham and Women's Cancer Center / Massachusetts General Hospital Cancer Center, Boston, MA; Duke Comprehensive Cancer Center, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; Arthur G. James Cancer Hospital& Richard J. Solove Research Institute at The Ohio State University, Columbus, OH; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa, FL; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.

click here to see enlargement of the map

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. For more information, visit www.nccn.org.